Live
- Thanks to Centre, AP on fast-track mode
- First Impressions and Unboxing of the MacBook Pro M4: A Powerhouse for Professionals and Creators
- China Gears Up for Potential Trade War Amid Trump’s Tariff Threats
- Small Farmers Gain Less by Selling to Supermarkets: Study Reveals
- Why Despite the Controversy, America Is Anticipating the Mike Tyson vs. Jake Paul Fight
- Sanju Samson and Tilak Varma Shine: Record-Breaking Feats in 4th T20I Against South Africa
- India Urges $1.3 Trillion Annual Climate Support for Developing Nations
- Bad air: 106 shuttle buses, 60 extra Metro trips planned to make Delhiites give up cars
- WHO reports declining monkeypox cases in Congo
- CM Attends Kotideepotsavam on Kartika Purnima
Divi’s Lab shares soar 17% up
Positive news from the US lifted share price of Divi’s Laboratories on Thursday. Its stock surged 16.73 per cent to end at Rs 1,074.30 on BSE.
Hyderabad: Positive news from the US lifted share price of Divi’s Laboratories on Thursday. Its stock surged 16.73 per cent to end at Rs 1,074.30 on BSE.
The market capitalisation of the company rose by Rs4,088.29 crore to Rs28,519.29 crore. Divi’s Laboratories said the US health regulator will lift an import alert imposed on the company's Unit-II in Visakhapatnam and is moving to close out the warning letter issued to the unit.
- US FDA may lift import alert on Vizag unit; mcap rises by Rs 4,088 cr
During intra-session, the stock rose sharply by 21.37 per cent to Rs1,117. On NSE, shares of the company soared 16.15 per cent to close at Rs 1,072.90. In terms of equity volume, 12.17 lakh shares of the company were traded on BSE and over one crore shares changed hands on NSE during the day.
Divi’s Lab in a communique to BSE said that it was informed by US FDA that it will be lifting the Import Alert 66-40 and move to close out the warning letter issued to the company’s Unit-II at Visakhapatnam.
